Princeton Capital Management Inc. held its stake in Osiris Therapeutics Inc. (NASDAQ:OSIR) during the second quarter, Holdings Channel reports. The fund owned 34,825 shares of the company’s stock at the end of the second quarter. Princeton Capital Management Inc. owned about 0.10% of Osiris Therapeutics worth $177,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of OSIR. Jacobs Levy Equity Management Inc. acquired a new stake in shares of Osiris Therapeutics during the first quarter valued at approximately $331,000. TIAA CREF Investment Management LLC boosted its stake in shares of Osiris Therapeutics by 7.3% in the first quarter. TIAA CREF Investment Management LLC now owns 60,675 shares of the company’s stock valued at $346,000 after buying an additional 4,121 shares in the last quarter. Eqis Capital Management Inc. boosted its stake in shares of Osiris Therapeutics by 4.2% in the second quarter. Eqis Capital Management Inc. now owns 123,617 shares of the company’s stock valued at $629,000 after buying an additional 4,944 shares in the last quarter. Geode Capital Management LLC boosted its stake in shares of Osiris Therapeutics by 10.0% in the first quarter. Geode Capital Management LLC now owns 122,535 shares of the company’s stock valued at $699,000 after buying an additional 11,129 shares in the last quarter. Finally, State Street Corp boosted its stake in shares of Osiris Therapeutics by 3.9% in the first quarter. State Street Corp now owns 294,046 shares of the company’s stock valued at $1,677,000 after buying an additional 11,117 shares in the last quarter. Hedge funds and other institutional investors own 20.67% of the company’s stock.

Shares of Osiris Therapeutics Inc. (NASDAQ:OSIR) traded down 1.39% during midday trading on Tuesday, hitting $4.97. 82,743 shares of the stock traded hands. The company has a market capitalization of $171.23 million, a price-to-earnings ratio of 118.33 and a beta of 0.53. The firm’s 50-day moving average is $5.24 and its 200 day moving average is $5.31. Osiris Therapeutics Inc. has a 52 week low of $3.55 and a 52 week high of $19.69.

Osiris Therapeutics Company Profile

Osiris Therapeutics, Inc is a medical products company. The Company is focused on developing and marketing products in regenerative medicine, including bioengineering, stem cell research and viable tissue based products. The Company’s offers products in orthopedics, sports medicine and wound care, including Cartiform, BIO4 and Grafix.

5 Day Chart for NASDAQ:OSIR

Want to see what other hedge funds are holding OSIR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Osiris Therapeutics Inc. (NASDAQ:OSIR).

Receive News & Ratings for Osiris Therapeutics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Osiris Therapeutics Inc. and related companies with MarketBeat.com's FREE daily email newsletter.